<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2020-5-45-55</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-1967</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERIMENTAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Влияние лития хлорида на активацию нейтрофилов под действием сыворотки пациентов с септическим шоком</article-title><trans-title-group xml:lang="en"><trans-title>The Effect of Lithium Chloride on Neutrophil Activation on Exposure to Serum of Patients with Septic Shock</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гребенчиков</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Grebenchikov</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гребенчиков Олег Александрович.107031, Москва, ул. Петровка, д. 25, стр. 2.</p></bio><bio xml:lang="en"><p>Oleg A. Grebenchikov.25 Petrovka Str., Bldg. 2, 107031 Moscow.</p></bio><email xlink:type="simple">oleg.grebenchikov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Касаткина</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kasatkina</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>107031, Москва, ул. Петровка, д. 25, стр. 2.</p></bio><bio xml:lang="en"><p>Irina S. Kasatkina.25 Petrovka Str., Bldg. 2, 107031 Moscow.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каданцева</surname><given-names>К. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Kadantseva</surname><given-names>K. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каданцева Кристина Кирилловна.107031, Москва, ул. Петровка, д. 25, стр. 2.</p></bio><bio xml:lang="en"><p>Kristina K. Kadantseva.25 Petrovka Str., Bldg. 2, 107031 Moscow.</p></bio><email xlink:type="simple">kristina161093@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мешков</surname><given-names>М. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Meshkov</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>107031, Москва, ул. Петровка, д. 25, стр. 2.</p></bio><bio xml:lang="en"><p>Mikhail A. Meshkov.25 Petrovka Str., Bldg. 2, 107031 Moscow.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bayeva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>107031, Москва, ул. Петровка, д. 25, стр. 2.</p></bio><bio xml:lang="en"><p>Anastasiya A. Bayeva.25 Petrovka Str., Bldg. 2, 107031 Moscow.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ общей реаниматологии им. В.А. Неговского ФНКЦ РР</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>06</day><month>11</month><year>2020</year></pub-date><volume>16</volume><issue>5</issue><fpage>45</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гребенчиков О.А., Касаткина И.С., Каданцева К.К., Мешков М.A., Баева А.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Гребенчиков О.А., Касаткина И.С., Каданцева К.К., Мешков М.A., Баева А.А.</copyright-holder><copyright-holder xml:lang="en">Grebenchikov O.A., Kasatkina I.S., Kadantseva K.K., Meshkov M.A., Bayeva A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/1967">https://www.reanimatology.com/rmt/article/view/1967</self-uri><abstract><p>Цель исследования — изучить противовоспалительное действие хлорида лития путем воздействия на нейтрофилы человека сыворотки пациентов с септическим шоком in vitro.Материал и методы. Исследование проводили на выделенных из крови 6 здоровых доноров нейтрофилах, которые активировали с помощью сыворотки пациентов с септическим шоком, после чего оценивали их активность с помощью флуоресцентных антител к маркерам дегрануляции CD11b и CD66b. Уровень апоптоза и некроза нейтрофилов человека оценивали через 22 часа после выделения; количественная оценка была проведена с использованием аннексина V и йодистого пропидия на проточном цитофлуориметре. Интактные и активированные нейтрофилы обрабатывали раствором хлорида лития в концентрациях 0,3; 3,0 и 9 ммоль.Результаты. Уровень экспрессии CD11b на поверхности интактных нейтрофилов (здоровые доноры) составил 3434,50 [3311,0-3799,0] условных единиц флуоресценции (у.е.ф.). Инкубация нейтрофилов с сывороткой крови пациентов с септическим шоком увеличивала экспрессию CD11b в 2,5 раза — 8589,0 [7279,0-11258,0] у.е.ф. (р=0,005) в сравнении с интактными лейкоцитами, и увеличивала экспрессию CD66b в 2,7 раза до 27 600,0 [22 999,0-28 989,0] у.е.ф. (р=0,005) в сравнении с интактными нейтрофилами. Лития хлорид дозозависимо в концентрациях — 0,3 ммоль, 3,0 и 9,0 ммоль снижал уровень экспрессии молекул CD11b и CD66b на поверхности активированных нейтрофилов. Септическая сыворотка уменьшала спонтанный апоптоз нейтрофилов, а раствор лития хлорида в дозе 3 ммоль и выше индуцировал спонтанный апоптоз нейтрофилов.Заключение. Хлорид лития снижает степень активации нейтрофилов, предварительно активированных сывороткой пациентов с септическим шоком, снижает уровень экспрессии молекул CD11b и CD66b на поверхности нейтрофилов, ингибируя процесс их активации (дегрануляции). Лития хлорида в концентрации 3 ммоль и выше способен индуцировать спонтанный апоптоз нейтрофилов, активированных сыворотками пациентов с септическим шоком.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study: to examine the anti-inflammatory effect of lithium chloride by exposing the human neutrophils to serum of patients with septic shock in vitro.Material and methods. The study was carried out on neutrophils extracted from the blood of 6 healthy donors, which were activated with serum from patients with septic shock. The neutrophil activity was evaluated with fluorescent antibodies to the CD11b and CD66b markers of degranulation. The level of human neutrophil apoptosis and necrosis was assessed 22 hours after extraction; quantitative assessment was made using annexin V and propidium iodide with flow cytofluorimetry. Intact and activated neutrophils were treated with 0.3, 3.0 and 9.0 mmol lithium chloride solution.Results. The level of CD11b expression on the surface of intact neutrophils (healthy donors) was 3434.50 [3311.0-3799.0] arbitrary fluorescence units (AFU). Incubation of neutrophils with serum of patients with septic shock increased CD11b expression 2.5 times to 8589.0 [7279.0-11258.0] AFU (P=0.005) vs intact leukocytes, and increased CD66b expression 2.7 times up to 27 600.0 [22 999.0-28 989.0] AFU ((P=0.005) vs intact neutrophils. Lithium chloride in concentrations of 0.3, 3.0 and 9.0 mmol in a dose-dependent manner reduced the level of expression of CD11b and CD66b molecules on the surface of activated neutrophils. Septic serum reduced spontaneous neutrophil apoptosis, and 3.0 mmol and higher lithium chloride solution induced spontaneous neutrophil apoptosis.Conclusion. Lithium chloride reduces the activation of neutrophils preactivated by serum of patients with septic shock, reduces expression of CD11b and CD66b molecules on the neutrophil surface, inhibiting the process of their activation (degranulation). Lithium chloride in concentration of 3.0 mmol and higher is able to induce spontaneous apoptosis of neutrophils activated by serum of patients with septic shock.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>септический шок</kwd><kwd>апоптоз нейтрофилов</kwd><kwd>лития хлорид</kwd><kwd>CD11b</kwd><kwd>CD66b</kwd><kwd>гликогенсинтаза киназа-3β</kwd><kwd>GSK-3β</kwd></kwd-group><kwd-group xml:lang="en"><kwd>CD11b</kwd><kwd>CD66b</kwd><kwd>lithium chloride</kwd><kwd>GSK-Зβ: glycogen synthase kinase 3β</kwd><kwd>septic shock</kwd><kwd>neutrophil apoptosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Balk R.A. Systemic inflammatory response syndrome (SIRS): Where did it come from and is it still relevant today? Virulence. 2014; 5 (1): 20-26. DOI: 10.4161/viru.27135. PMID: 24280933.</mixed-citation><mixed-citation xml:lang="en">Balk R.A. Systemic inﬂammatory response syndrome (SIRS): Where did it come from and is it still relevant today? Virulence. 2014; 5 (1): 20–26. DOI: 10.4161/viru.27135. PMID: 24280933.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J-S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007; 55: 453-462. DOI: 10.1002/glia.20467. PMID: 17203472.</mixed-citation><mixed-citation xml:lang="en">Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J-S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinﬂammation and progressive neurodegeneration. Glia. 2007; 55: 453–462. DOI: 10.1002/glia.20467. PMID: 17203472.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Alexander J.J., Jacob A., Cunningham P., Hensley L., Quigg R.J. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008; 52: 447-456. DOI: 10.1016/j.neuint.2007.08.00.</mixed-citation><mixed-citation xml:lang="en">Alexander J.J., Jacob A., Cunningham P., Hensley L., Quigg R.J. TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1. Neurochem Int. 2008; 52: 447–456. DOI: 10.1016/j.neuint.2007.08.00.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Jaffer У., Wade R.G., Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc. Intensive Care Cardiovasc. Anesth. 2010; 2 (3): 161-175. PMID: 23441054.</mixed-citation><mixed-citation xml:lang="en">Jaﬀer U., Wade R.G., Gourlay T. Cytokines in the systemic inﬂammatory response syndrome: a review. HSR Proc. Intensive Care Cardiovasc. Anesth. 2010; 2 (3): 161–75. PMID: 23441054.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Parkos A., Colgan P., Madara J.L. Interaction of Neutrophils With Epithelial Cells: Lessons From the Intestine. J Am Soc Nephrol. 1994; 5 (2): 138-152. PMID: 7993993.</mixed-citation><mixed-citation xml:lang="en">Parkos A., Colgan P., Madara J.L. Interaction of Neutrophils With Epithelial Cells: Lessons From the Intestine. J Am Soc Nephrol.1994; 5 (2): 138–152. PMID: 7993993.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt T., ZundorfJ., GrUger T., Brandenburg K., Reiners A.L., Zin-serling J., Schnitzler N. CD66b overexpression and homotypic aggregation of human peripheral blood neutrophils after activation by a gram-positive stimulus. J. Leukoc. Biol. 2012; 91 ( 5): 791-802. DOI: 10.1189/jlb.0911483. PMID: 22319104.</mixed-citation><mixed-citation xml:lang="en">Schmidt T., Zündorf J., Grüger T., Brandenburg K., Reiners A.L., Zinserling J., Schnitzler N. CD66b overexpression and homotypic aggregation of human peripheral blood neutrophils after activation by a gram-positive stimulus. J. Leukoc. Biol. 2012; 91 ( 5): 791–802. DOI: 10.1189/jlb.0911483. PMID: 22319104.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lilius E.M., Nuutila J. Bacterial infections, DNA virus infections, and RNA virus infections manifest differently in neutrophil receptor expression. Scientific World Journal. 2012: 527347. DOI: 10.1100/2012/527347. PMID:22536142.</mixed-citation><mixed-citation xml:lang="en">Lilius E.M., Nuutila J. Bacterial infections, DNA virus infections, and RNA virus infections manifest diﬀerently in neutrophil receptor expression. Scientiﬁc World J. 2012: 527347. DOI: 10.1100/2012/527347. PMID: 22536142.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Muller Kobold A., Tulleken J.E., Zijlstra J.G., Sluiter W., Hermans J. Leukocyte activation in sepsis; Correlations with disease state and mortality. Intensive Care Med. 2000 Jul; 26 (7): 883-892. DOI: 10.1007/s001340051277. PMID: 10990102.</mixed-citation><mixed-citation xml:lang="en">Muller Kobold A., Tulleken J.E., Zijlstra J.G., Sluiter W., Hermans J. Leukocyte activation in sepsis; Сorrelations with disease state and mortality. Intensive Care Med. 2000 Jul; 26 (7): 883–892. DOI: 10.1007/s001340051277. PMID: 10990102.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Boomer J.S., Green J.M., Hotchkiss R.S. The changing immune system in sepsis. Virulence. 2014; 5 (1): 45-56. DOI: 10.4161/viru.26516. PMID: 24067565.</mixed-citation><mixed-citation xml:lang="en">Boomer J.S., Green J.M., Hotchkiss R.S. The changing immune system in sepsis. Virulence. 2014; 5 (1): 45–56. DOI: 10.4161/viru.26516. PMID: 24067565.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proc. Natl.Acad. Sci. 1996; 93 (16): 8455-8459. DOI: 10.1073/pnas.93.16.8455. PMID: 8710892.</mixed-citation><mixed-citation xml:lang="en">Klein P.S., Melton D.A. A molecular mechanism for the eﬀect of lithium on development. Proc. Natl.Acad. Sci. 1996; 93 (16): 8455–8459. DOI: 10.1073/pnas.93.16.8455. PMID: 8710892.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Stambolic V., Ruel, L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 1996 Dec 1; 6 (12): 1664-1668. DOI: 10.1016/s0960-9822 (02)70790-2. PMID: 8994831.</mixed-citation><mixed-citation xml:lang="en">Stambolic V., Ruel, L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 1996 Dec 1; 6 (12): 1664–1668. DOI: 10.1016/s0960-9822(02)70790-2. PMID: 8994831.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase ki-nase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 2004; 113 (11): 1535-1549. DOI: 10.1172/JCI19906. PMID: 15173880</mixed-citation><mixed-citation xml:lang="en">Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3beta mediatesconvergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 2004; 113 (11): 1535–1549. DOI: 10.1172/JCI19906. PMID: 15173880.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Васильева А.К., Плотников Е.Ю., Казаченко А.В., Кирпатовский В.И., Зоров Д.Б. Ингибирование GSK_3b снижает индуцированную ишемией гибель клеток почки. Бюлл. Эксп. Биол. Мед. 2010; 149 (3): 276-281.</mixed-citation><mixed-citation xml:lang="en">Vasilyeva A.K., Plotnikov E.Yu., Kazachenko A.V., Kirpatovsky V.I., Zorov D.B. Inhibition of GSK_3b reduces ischemia-induced renal cell death. Bull. Exp. Biol. Med. 2010; 149 (3): 276–281. [In Russ.].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Гребенчиков О.А., Лобанов А.В., Шайхутдинова Э.Р., Кузовлев А.Н., Ершов А.В., Лихванцев В.В. Кардиопротекторные свойства хлорида лития на модели инфаркта миокарда у крыс. Патология кровообращения и кардиохирургия. 2019; 23 (2): 43-49. DOI: 10.21688/1681-3472-2019-2-43-49.</mixed-citation><mixed-citation xml:lang="en">Grebenchikov O.A., Lobanov A.V., Shaikhutdinova E.R., Kuzovlev A.N., Ershov A.V., Likhvantsev V.V. Cardioprotective eﬀect of lithium chloride on a rat model of myocardial infarction. Patologiya krovoobrashcheniya I kardiokhirurgiya. 2019; 23 (2): 43–49. DOI: 10.21688/1681-3472-2019-2-43-49. [In Russ.].</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Острова И.В., Гребенчиков О.А., Голубева Н.В. Нейропротектив-ное действие хлорида лития на модели остановки сердца у крыс (экспериментальное исследование). Общая реаниматология. 2019; 15 (3): 73-82. DOI: 10.15360/1813-9779-2019-3-73-82.</mixed-citation><mixed-citation xml:lang="en">Ostrova I.V., Grebenchikov O.A., Golubeva N.V. Neuroprotective Eﬀect of Lithium Chloride in Rat Model of Cardiac Arrest. General Reanimatology=Obshchaya Reanimatologiya. 2019; 15 (3): 73–82. DOI: 10.15360/1813-9779-2019-3-73-82. [In Russ.].</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Albayrak A., Halici Z., Polat B., Karakus E., Cadirci E., Bayir Y., Kunak S., Karcioglu S.S., Yigit S., Unal D., Atamanalp S.S. Protective effects of lithium: a new look at an old drug with potential antioxidative and antiinflammatory effects in an animal model of sepsis. Int. mmunopharmacol. 2013; 16 (1): 35-40. DOI: 10.1016/j.intimp.2013.03.018. PMID: 23542012.</mixed-citation><mixed-citation xml:lang="en">Albayrak A., Halici Z., Polat B., Karakus E., Cadirci E., Bayir Y., Kunak S., Karcioglu S.S., Yigit S., Unal D., Atamanalp S.S. Protective eﬀects of lithium: a new look at an old drug with potential antioxidative and antiinﬂammatory eﬀects in an animal model of sepsis. Int. mmunopharmacol. 2013; 16 (1): 35–40. DOI: 10.1016/j.intimp.2013.03.018. PMID: 23542012.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Haimovich A., EliavU., Goldbourt A Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR. J. Am. Chem.Soc. 2012;134 (12): 5647-5651. DOI: 10.1021/ja211794x. PMID: 22384802.</mixed-citation><mixed-citation xml:lang="en">Haimovich A., Eliav U., Goldbourt A. Determination of the lithium binding site in inositol monophosphatase, the putative target for lithium therapy, by magic-angle-spinning solid-state NMR. J. Am. Chem.Soc. 2012;134 (12): 5647–5651. DOI: 10.1021/ja211794x. PMID: 22384802.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Мороз В.В., Силачев Д.Н., Плотников Е.Ю., Зорова Л.Д., Певзнер И.Б., Гребенчиков О.А., Лихванцев В.В. Механизмы повреждения и защиты клетки при ишемии/реперфузии и экспериментальное обоснование применения препаратов на основе лития в анестезиологии Общая реаниматология. 2013. 9 (1): 63-72.</mixed-citation><mixed-citation xml:lang="en">Moroz V.V., Silachev D.N., Plotnikov E.Yu., Zorova L.D., Pevzner I.B., Grebenchikov O.A., Likhvantsev V.V. Mechanisms of cell damage and protection in ischemia/reperfusion and experimental rationale for the use of lithium-based preparations in anesthesiology. General Reanimatology=Obshchaya Reanimatologiya. 2013. 9 (1): 63–72.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yu F., Wang Z., Tchantchou F., Chiu C.T., Zhang Y., Chuang D.M. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. J. Neurotrauma. 2012; 29 (2): 362-374. DOI: 10.1089/neu.2011.1942. PMID: 21895523.</mixed-citation><mixed-citation xml:lang="en">Yu F., Wang Z., Tchantchou F., Chiu C.T., Zhang Y., Chuang D.M. Lithium ameliorates neurodegeneration, suppresses neuroinﬂammation, and improves behavioral performance in a mouse model of traumatic brain injury. J. Neurotrauma. 2012; 29 (2): 362–374. DOI: 10.1089/neu.2011.1942. PMID: 21895523.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hofmann C., Dunger N., Scholmerich J., Falk W.,Obermeier F. Glycogen synthase kinase 3-beta: a master regulator of toll-like receptor-mediated chronic intestinal inflammation, Inflamm. Bowel Dis. 2010 Nov; 16 (11):1850-1858. DOI: 10.1002/ibd.21294. PMID: 20848477.</mixed-citation><mixed-citation xml:lang="en">Hofmann C., Dunger N., Scholmerich J., Falk W.,Obermeier F. Glycogen synthase kinase 3-beta: a master regulator of toll-like receptormediated chronic intestinal inﬂammation, Inﬂamm. Bowel Dis. 2010 Nov; 16 (11): 1850–1858. DOI: 10.1002/ibd.21294. PMID: 20848477.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Seymour C.W., Liu V.X., Iwashyna TJ. BrunkhorstF.M., Rea T.D., Andri ScheragA., Rubenfeld G., Kahn J.M., Shankar-Hari M., Singer M., De-utschman S.C., Escobar G.J., Angus D.S. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315 (8): 762-774. DOI: 10.1001/jama.2016.0288. PMID: 26903335.</mixed-citation><mixed-citation xml:lang="en">Seymour C.W., Liu V.X., Iwashyna T.J. Brunkhorst F.M., Rea T.D., André Scherag A., Rubenfeld G., Kahn J.M., Shankar-Hari M., Singer M., Deutschman S.C., Escobar G.J., Angus D.S. Assessment of clinical criteria for sepsis: for the Third International Consensus Deﬁnitions for Sepsis andSeptic Shock (Sepsis-3). JAMA. 2016; 315 (8): 762–774. DOI: 10.1001/jama.2016.0288. PMID: 26903335.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">PillayJ., Braber I., Vrisekoop N., KwastL.M., Boer R.J., Borghans J., Tes-selaar K., Koenderman L. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood. 2010; 116 (4): 625-627. DOI: 10.1182/blood-2010-01-259028. PMID: 20410504.</mixed-citation><mixed-citation xml:lang="en">Pillay J., Braber I., Vrisekoop N., Kwast L.M., Boer R.J., Borghans J., Tesselaar K., Koenderman L. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood. 2010; 116 (4): 625–627. DOI: 10.1182/blood-2010-01-259028. PMID: 20410504.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bartels M., Murphy K., Rieter E., Bruin M. Understanding chronic neutropenia: Life is short. British Journal of Haematology. 2016; 172 (2): 157-169. DOI: 10.1111/bjh.13798. PMID: 26456767.</mixed-citation><mixed-citation xml:lang="en">Bartels M., Murphy K., Rieter E., Bruin M. Understanding chronic neutropenia: Life isshort. British Journal of Haematology. 2016; 172 (2): 157–169. DOI: 10.1111/bjh.13798. PMID: 26456767.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Petrini M., Azzara A. Lithium in the Treatment of Neutropenia. Curr Opin Hematol. 2012 Jan; 19 (1): 52-57. DOI: 10.1097/MOH.0b013e 32834da93b. PMID: 22123660.</mixed-citation><mixed-citation xml:lang="en">Petrini M., Azzarà A. Lithium in the Treatment of Neutropenia. Curr Opin Hematol. 2012 Jan; 19 (1): 52–57. DOI: 10.1097/MOH.0b013e32834da93b. PMID: 22123660.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
